Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial.
- DOI
- 10.3389/fphar.2023.1221905
- Published
- 2023
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2023.1221905,
title = {Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial.},
author = {Willcox ML and Hu XY and Oliver T and Thorne K and Boxall C and He G and Simpson C and Brotherwood B and O'Neil A and Waugh R and Tilt E and Trill J and Goward N and Francis N and Thomas M and Little P and Wilkinson T and Liu JP and Griffiths G and Moore M},
year = {2023},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2023.1221905},
url = {https://doi.org/10.3389/fphar.2023.1221905}
}RIS
TY - JOUR TI - Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial. AU - Willcox ML AU - Hu XY AU - Oliver T AU - Thorne K AU - Boxall C AU - He G AU - Simpson C AU - Brotherwood B AU - O'Neil A AU - Waugh R AU - Tilt E AU - Trill J AU - Goward N AU - Francis N AU - Thomas M AU - Little P AU - Wilkinson T AU - Liu JP AU - Griffiths G AU - Moore M PY - 2023 JO - Frontiers in pharmacology DO - 10.3389/fphar.2023.1221905 UR - https://doi.org/10.3389/fphar.2023.1221905 ER -
APA
ML, W., XY, H., T, O., K, T., C, B., G, H., C, S., B, B., A, O., R, W., E, T., J, T., N, G., N, F., M, T., P, L., T, W., JP, L., G, G., & M, M. (2023). Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2023.1221905
Source records
- pubmed · retrieved 2026-09-26T11:24:05.160Z